All times are listed in CEST (Central European Summer Time)
Special session
Date
Mon, 12.09.2022
Time
16:30 - 18:00
Location
4.B - Brest Auditorium
Chairs
- Jarushka Naidoo (Dublin, Ireland)
- Erica Mayer (Boston, United States of America)
Session Type
Special session
Special session
Introduction and scientific background
Speakers
- Erica Mayer (Boston, United States of America)
Lecture Time
16:30 - 16:40
Session Name
Location
4.B - Brest Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 12.09.2022
Time
16:30 - 18:00
Special session
Critical organ damage and late toxicities from anti-PD1
Speakers
- Jarushka Naidoo (Dublin, Ireland)
Lecture Time
16:40 - 16:55
Session Name
Location
4.B - Brest Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 12.09.2022
Time
16:30 - 18:00
Special session
Late haematological malignancies of systemic anticancer therapies
Speakers
- Jean Baptiste Micol (Villejuif, Cedex, France)
Lecture Time
16:55 - 17:10
Session Name
Location
4.B - Brest Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 12.09.2022
Time
16:30 - 18:00
Special session
Chronic toxicities of targeted therapies and their implication on compliance: Illustration with new endocrine therapies and CDK4 inhibitors
Speakers
- Erica Mayer (Boston, United States of America)
Lecture Time
17:10 - 17:25
Session Name
Location
4.B - Brest Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 12.09.2022
Time
16:30 - 18:00
Special session
Toxicities of CAR T cell and bispecific
Speakers
- Claire Roddie (London, United Kingdom)
Lecture Time
17:25 - 17:40
Session Name
Location
4.B - Brest Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 12.09.2022
Time
16:30 - 18:00
Special session
Discussion: How to design better trial taking into account toxicities
Speakers
- All Speakers (Lugano, Switzerland)
Lecture Time
17:40 - 18:00
Session Name
Location
4.B - Brest Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 12.09.2022
Time
16:30 - 18:00